![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/48 | |
A61P 17/00 | |||
A61P 29/00 |
(11) | Number of the document | 2037956 |
(13) | Kind of document | T |
(96) | European patent application number | 07788861.8 |
Date of filing the European patent application | 2007-06-11 | |
(97) | Date of publication of the European application | 2009-03-25 |
(45) | Date of publication and mention of the grant of the patent | 2012-12-12 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/FR2007/000956 |
Date | 2007-06-11 |
(87) | Number | WO 2007/144493 |
Date | 2007-12-21 |
(30) | Number | Date | Country code |
0605368 | 2006-06-16 | FR |
(72) |
AUGUET, Michel, FR
FAVRE, Christine, FR
CHABRIER DE LASSAUNIERE, Pierre-Etienne, FR
|
(73) |
IPSEN PHARMA,
65 Quai Georges Gorse, 92100 Boulogne-Billancourt,
FR
|
(54) | UTILISATION THERAPEUTIQUE SIMULTANEE, SEPAREE OU ETALEE DANS LE TEMPS D`AU MOINS UNE NEUROTOXINE BOTULIQUE, ET D`AU MOINS UN DERIVE OPIACE |
SIMULTANEOUS, SEPARATE OR SEQUENTIAL THERAPEUTIC USE OF AT LEAST ONE BOTULINUM NEUROTOXIN AND OF AT LEAST ONE OPIATE DERIVATIVE |